Tuesday, 31 Mar 2020


Datesort ascending Type Title Save
10 Sep 2019 News Riociguat Fails in Systemic Sclerosis-Associated Digital Ulcers
09 Sep 2019 News Nintedanib FDA Approved for Scleroderma Lung Disease
09 Sep 2019 Social FDA Approves Ofev (nintedanib) for Interstitial Lung Disease Associated with Systemic Sclerosis or Scleroderma (SSc-ILD) https://t.co/nTrENZmaqR PI: https://t.co/1kZygrH8E7
03 Sep 2019 Social Drug use by #SLE patients during 376 pregnancies (284 women) was studied. HCQ was used in 24.2%, but was discontinued 17% in the year prior, 30% in 1st trimester, 10% in 2nd trimester & 26% in 3rd trimester. Education on utility of HCQ during Pred needed! https://t.co/SxQW8vpjVO
03 Sep 2019 Social Taiwanese matched cohort study shows that #SLE patients with acute MI have higher mortality rate and prolonged hospitalization after AMI. Aggressive control may decrease risk of AMI for SLE patients. https://t.co/vvEo7ZuboA
30 Aug 2019 Social Anifrolumab (anti-IFNa) was shown to be effective in its 2nd phase III trial in SLE - meeting its primary (BiCLA) endpoint at week 52, according to an Astra-Zeneca press release. Full data to be presented at an upcoming medical meeting. https://t.co/SLaQHJS6WY
29 Aug 2019 Social Among 312 Lupus patients, epilepsy seen in 36 (11.5%)- 30 had focal onset. Half had NPSLE. NPSLE + Epilepsy were more likely to have APS; and Cerebrovascular dz & psychosis were 2-3 fold higher (compare to NPSLE without epilepsy (p<0.001). https://t.co/jOb4WkbxL4
29 Aug 2019 Social RT @karen_kc123: I recently spoke with Rheumatology Advisor, where we discussed an important issue -the barriers in SLE diagnosis, care, an…
26 Aug 2019 Social Full read review of "Management of Refractory Lupus Nephritis" https://t.co/Cu4QckxRIo
14 Aug 2019 News With Autoimmunity, Checkpoint Inhibitors Can Be Used
10 Aug 2019 Social The RheumNow Podcast is up! "Tricked Up Lupus Criteria" and more on gout & ULT, IVIG in ANCA vasculitis, NO SIE risk w/ TNFi, and the Best 1st Biologic. Watch the video here>> https://t.co/j1Axn36hL0 or listen to the Podcast on iTUNEs or SoundCloud here>> https://t.co/rjAQmxHce6
09 Aug 2019 Social IL-16 studied in Scleroderma: incr perivasc IL-16 lymphocyte expression w/ more IL-16+ cells in dcSSc vs lcSSc (44 vs 29%, P<0.05). Serum IL-16 levels elevated in SSc pts (297 vs 195 pg/ml) & IL-16 correlated w/ dcSSc, skin score, erythema & pigmentation. https://t.co/lC4nRO6AH0
07 Aug 2019 News New EULAR/ACR Classification Criteria for SLE
02 Aug 2019 News Sjogren's Syndrome at Risk for Psychiatric Disorders
01 Aug 2019 Social Candian study of 376 pregnancies (284 F) with #SLE and drug use: only 24.2% on antimalarials, 8.2% azathioprine, 19.7% steroids & 4.8% on NSAIDs during pregnancy. 1st trimester discontinuations seen in 16.7% of HCQ & 29.2% AZA https://t.co/YoRUXU9RJB
30 Jul 2019 Social Cohort study shows ACE inhib. in Systemic Sclerosis at Dx was assoc w/ increased risk for Scleroderma Renal Crisis (SRC). Military System EHR study of 31 SRC to 332 non-SRC & found ACEi assoc w/ SRC (OR 4.1; CI 1.6–10.2) only in presence of proteinuria https://t.co/cMsheXrmRY
29 Jul 2019 News Abatacept Disappoints in Systemic Sclerosis
25 Jul 2019 News FDA AAC Splits Vote in Favor of Nintedanib for Scleroderma Interstitial Lung Disease
22 Jul 2019 Social Study from National Inpatient Sample (2002-11) , 424 hospitals, 4024 #SLE pts admitted w/ sepsis. Mortality varied from 0-60%. Hospitals that treated ⩾3.9 patients with SLE and sepsis annually had a lower risk of lupus mortality (10% vs 17%; P = 0.004). https://t.co/TuVfaGUpcM
22 Jul 2019 News FDA Approves Apremilast for Behcet's Oral Ulcers